Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
3317301
Title:
POLYTHÉRAPIES COMPRENANT DES MOLÉCULES D'ANTICORPS DIRIGÉES CONTRE LAG-3
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
167573914
WO application number:
US2016044545
Type:
European patent granted for BE
Status:
Open
Publication number:
3317301
WO publication number:
WO2017019894
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
28/07/2016
Grant date:
07/04/2021
EP publication date:
09/05/2018
WO publication date:
02/02/2017
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
07/04/2021
EP B1 publication date:
07/04/2021
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
28/07/2036
Applicant
1
Name:
Novartis AG
Legal Form:
From:
25/06/2021
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)
To:
2
Name:
Immutep S.A.S.
Legal Form:
From:
25/06/2021
Address:
21 Rue Jean Rostand, 91893 Orsay Cedex, France (FR)